Halychpharm Logo

Halychpharm

A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.

GFARM | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000105993
LEI:
Country:
Ukraine
Address:
Opryshkivska vulytsia 6, 79024 Lviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Halychpharm, a member company of the Arterium Corporation, is a pharmaceutical manufacturer specializing in finished medicinal products. The company is a key producer of phytochemical substances derived from the extraction of medicinal plant raw materials. Its portfolio includes a range of medications designed to meet various therapeutic needs, providing high-quality treatments to patients and consumers. Halychpharm supports the entire patient treatment journey, from developing new products for unmet medical needs to ensuring drug safety through pharmacovigilance.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Halychpharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Halychpharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Halychpharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celltrion, Inc. Logo
A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.
South Korea
068270
Celltrion Pharm Inc. Logo
South Korea
068760
Develops bone grafts, artificial joints, and enzymes for the biopharmaceutical sector.
South Korea
049180
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland
CLN
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
Century Therapeutics, Inc. Logo
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
United States of America
IPSC
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden
CRNO
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CERUS CORP Logo
Develops pathogen reduction technology to safeguard the global blood supply for healthcare providers.
United States of America
CERS

Talk to a Data Expert

Have a question? We'll get back to you promptly.